Work

Bidirectional regulatory roles of COMMD1 in tumorigenesis and progression: Translational prospects as a diagnostic and therapeutic target (Review)

Year: 2026
Type: review
Abstract: Copper metabolism MURR1 domain‑containing protein 1 (COMMD1) is one of the best‑characterised members of the COMMD protein family. Initially identified as a key regulator of copper ion homeostasis, accumulating evidence has shown that COMMD1 does not function as a canonical tumour suppressor or oncogene in malignant tumours. Instead, it serves as a context‑dependent molecular hub whose activity is dynamically influenced by cellular background, signalling pathway status and post‑translational modifications. On the one hand, COMMD1 exerts antitumour effects by inhibiting NF‑κB and hypoxia‑inducible factor‑1 signalling, regulating DNA damage repair, modulating cell cycle progression and enhancing apoptotic sensitivity. Conversely, in certain tumour types, COMMD1 may promote drug resistance and adaptive tumour evolution by preserving DNA repair capacity, supporting cell survival or modulating ubiquitination networks. This review systematically summarises the differential expression patterns and functional mechanisms of COMMD1 in lung cancer, prostate cancer, ovarian cancer, hepatocellular carcinoma, multiple myeloma, neuroblastoma and breast cancer, with particular emphasis on its pivotal roles in the inflammatory immune microenvironment, hypoxic adaptation, genomic stability and drug sensitivity. Furthermore, translational strategies targeting COMMD1 are discussed, including COMMD1‑dependent peptide therapeutics, small‑molecule stabilisers, copper chelation‑based combination therapies and gene regulatory interventions. Collectively, the evidence supports COMMD1 as a potential integrated diagnostic and therapeutic target in precision oncology. However, its tissue‑specific and bidirectional functions highlight the need for further mechanistic investigation and patient stratification to enable precise clinical translation.
Institution: Putian University
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W7236034946
FWCI:
Cites: 98
Cited by:
Related to: 10